BioSpace News Archive

Serimmune announced today the publication of a study in Nature in which their proprietary Serum Epitope Repertoire Analysis (SERA) technology platform was one of the methods used to analyze the biological processes associated with the development and persistence of Long COVID symptoms, such as fatigue, brain fog and malaise.

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX) today announced the entrance into a manufacture and supply agreement with Varex Imaging Corporation (“Varex,” Nasdaq: VREX), a leading innovator, designer and manufacturer of X-ray imaging components, under which Varex will supply X-ray tubes utilizing the Nanox digital X-ray source for the Nanox.ARC system.

SS Innovations International, Inc. announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.

Femasys Inc. today announced that it has successfully completed the annual Medical Device Single Audit Program (MDSAP) surveillance audit with no nonconformances and no findings.

Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today an update on its ongoing Phase 1/2 clinical trial evaluating KVA12123 in patients with advanced solid tumors.

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate at the Roth MKM Healthcare Opportunities Conference in New York. Delcath CEO, Gerard Michel will present on October 12 at 11:45 AM ET.

Ichnos Sciences Inc. today announced the promotion of Dean Thomas to the position of General Counsel, effective immediately.

Neurodon announced today that it has been awarded approximately $2.9 million in continued funding under its Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).

Hamilton Company, a specialist in automation technology and analytical sensors, announced the introduction of its redesigned VisiFerm™ SU RS485-ECS to ensure supply safety.

Calliditas Therapeutics AB announced that its partner STADA Arzneimittel AG has submitted a request to the Medicines and Healthcare products Regulatory Agency of the United Kingdom to convert the conditional marketing authorization for Kinpeygo®, a treatment for primary IgA nephropathy, to standard, or “full”, marketing authorization.